[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Page 28071]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-9611]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 23, 2007, and published in the Federal 
Register on January 30, 2007, (72 FR 4296), American Radiolabeled 
Chemical, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
1-[1-(2-Thienyl) cyclohexyl] piperidine;     I
 TCP (7470).
Normorphine (9313).........................  I
Dextropropoxyphene, bulk (non-dosage form)   II
 (9273).
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances as radiolabeled compounds for biochemical 
research.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
American Radiolabeled Chemical, Inc. to manufacture the listed basic 
class of controlled substance is consistent with the public interest at 
this time. DEA has investigated American Radiolabeled Chemical, Inc. to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with State and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-9611 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P